• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

The REGROUP trial: endoscopic and open vein-graft harvest associated with similar outcomes

byJames RoebkerandDayton McMillan
January 13, 2019
in Cardiology, Surgery
Reading Time: 3 mins read
Cognitive outcomes in older adults undergoing cardiovascular procedures unclear
Share on FacebookShare on TwitterShare on LinkedIn

1. Among patients randomized to an open or endoscopic vein-graft harvest technique for coronary-artery bypass graft (CABG) surgery, there was no difference in major adverse cardiovascular events (MACE) over a median follow-up of 2.78 years.

2. The rate of leg wound complications was lower in the endoscopic-harvest group compared to the open-harvest group.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Patients undergoing CABG surgery usually have one or more vein grafts placed, which may be harvested using an open or endoscopic technique. Though studies have demonstrated lower rates of harvest-site complications and less pain with the endoscopic technique, vein-graft patency has been consistently lower compared to the open technique. Given that prior studies featured relatively small sample sizes with short follow-up, the Randomized Endovein Graft Prospective (REGROUP) trial was designed to assess clinical outcomes of open or endoscopic vein-graft harvesting in CABG surgery. Investigators found no significant difference in the primary outcome, the first occurrence of a MACE, between open and endoscopic vein-graft harvesting. Furthermore, there was no difference in any of the individual components of the primary outcome and the endoscopic technique was associated with a lower rate of wound complications compared to the open technique. The results suggest endoscopic harvest by an expert surgeon may be the preferred harvesting modality going forward, though further evidence with multiple arterial grafts and the open “no touch” vein-graft harvest technique may impact clinical practice.

This was the largest study to compare the open and endoscopic vein-graft harvest techniques for CABG. A key feature of this study was the high level of expertise required for vein harvesters. Limited information regarding operator expertise has been a criticism of previous studies, but this requirement also limits generalizability of this study’s results. Further limiting generalizability is the exclusion of the open “no touch” technique, which may have superior outcomes to traditional open harvesting.

Click to read the study in NEJM

RELATED REPORTS

Tissue oxygenation and haemodynamic monitoring does not augment postoperative monitoring in adults with coronary bypass

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

Relevant Reading: Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery

In-Depth [randomized controlled trial]: Patients (n=1150) at Veterans Affairs cardiac surgery centers who were undergoing elective or urgent CABG with at least one saphenous vein graft were randomly assigned to endoscopic (n=576) or open (n=574) vein-graft harvesting. Only endoscopic vein-graft harvesters with more than 100 endoscopic vein harvesting cases and <5% conversion rate to open harvesting were invited to participate in the trial. The open “no touch” technique of vein-graft harvesting was not practiced at any site in the study. Following randomization, patients were assessed at baseline, surgery, after surgery, at discharge, at six weeks, and every three months thereafter for a minimum of one year. The primary outcome was the first MACE (composite of death from any cause, nonfatal myocardial infarction, or repeat revascularization) in a time-to-event analysis over the active follow-up period. A secondary outcome included was MACE at one year after surgery. Individual components of the primary outcome, incisional leg pain, and leg wound infections were also assessed.

Median follow-up time was 2.78 years. During active follow-up, the primary outcome occurred in 89 patients (15.5%) in the open group versus 80 patients (13.9%) in the endoscopic group (hazard ratio [HR], 1.12; 95% confidence interval [CI], 0.83 to 1.51; P=0.47). In the open versus endoscopic group: death occurred in 46 patients (8.0%) versus 37 patients (6.4%) (HR, 1.25; 95% CI, 0.81 to 1.92), myocardial infarction occurred in 34 patients (5.9%) versus 27 patients (4.7%) (HR, 1.27; 95% CI, 0.77 to 2.11), and repeat revascularization occurred in 35 patients (6.1%) versus 31 patients (5.4%) (HZ, 1.14; 95% CI, 0.70 to 1.85), respectively. The one-year rate of MACEs was 8.2% versus 7.8% for the open and endoscopic groups, respectively. Leg wound infections occurred in 18 patients (3.1%) in the open group versus 8 patients (1.4%) in the endoscopic group (relative risk [RR], 2.26; 95% CI, 0.99 to 5.15). There was no functional impairment from incisional leg pain in 62.2% of patients in the open group versus 79.1% in the endoscopic group (RR, 0.79; 95% CI, 0.73 to 0.85).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: CABGoronary artery bypass surgeryvein graft
Previous Post

#VisualAbstract: Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children The PRIME Randomized Clinical Trial

Next Post

#VisualAbstract: Neoadjuvant degarelix versus triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: a randomized phase II trial

RelatedReports

Recovery after surgery collage: an older man in a hospital gown under an operating lamp, small walking scenes and a wristband
Cardiology

Tissue oxygenation and haemodynamic monitoring does not augment postoperative monitoring in adults with coronary bypass

April 5, 2025
Heart catheter procedures collage: a smiling older man with a white beard and an engraved heart with a blue guidewire
Cardiology

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

February 11, 2025
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Cardiology

Ticagrelor and aspiring dual antiplatelet therapy is favourable over monotherapy following coronary artery bypass

June 22, 2024
#VisualAbstract: Prophylactic methylprednisolone for cardiac surgery in infants does not improve post-operative outcomes
StudyGraphics

#VisualAbstract: Prophylactic methylprednisolone for cardiac surgery in infants does not improve post-operative outcomes

January 5, 2023
Next Post
#VisualAbstract: Neoadjuvant degarelix versus triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: a randomized phase II trial

#VisualAbstract: Neoadjuvant degarelix versus triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: a randomized phase II trial

Parents often unaware of adolescents’ suicidal thoughts

Young-onset type 2 diabetes associated with increased risk of hospitalization frequently due to mental illness

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis
  • Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty
  • 2 Minute Medicine Rewind November 2, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.